Abstract:BackgroundSerum thyroglobulin (Tg) is a key biomarker used to detect disease recurrence in patients with differentiated thyroid cancers who have undergone complete thyroidectomy. Thyroglobulin antibodies (TgAb) can interfere with accurate measurement of serum Tg levels, producing falsely low results in automated immunoassays. Thus before measurement of Tg, TgAb levels are measured to determine if in-house immunoassays can be used or if the patient's sample will need to be sent out for radioimmunoassay (RIA) or mass spectrometry methodologies, which are less sensitive to TgAb interference. We recently transitioned to new instrumentation and noted a sharp increase in Tg samples with TgAb interference that needed to be sent out when we used the limit of detection (LOD) of the Roche TgAb assay. This increases turnaround times for patients and increases laboratory costs. We hypothesized that the LOD of the Roche TgAb assay is below the level of interference in Tg immunoassays. To test this we compared the performance of TgAb immunoassays (IA) and Tg measurements by IA and RIA with the intention of proposing a more appropriate threshold for TgAb interference for the Roche TgAb assay.MethodsWe collected 121 serum specimens, which were above the LOD of the Roche TgAb (R-TgAb) assay, which is 10 IU/mL. These specimens were sent as part of standard care to USC for measurement of TgAb by Kronus (K-TgAb) and Tg by RIA. On these split samples we also measured Tg by Beckman Access (B-Tg). We compared the detection of TgAb by USC to varying thresholds of Roche TgAb measurements (10 IU/mL [LOD], 20 IU/mL, and 115 IU/mL [reference interval for autoimmunity]), and assessed the agreement between Tg measurements by Beckman IA and USC RIA for different Roche TgAb thresholds. Analyses were performed in Prism Graphpad using linear regression.ResultsQualitatively, the concordance for R-TgAb to RIA (reference) at 10 IU/mL was 31%, at 20 IU/mL was 90%, and at 115 IU/mL was 80%. Quantitative agreement between the B-Tg immunoassay and RIA for the TgAb thresholds of: TgAb >10 IU/mL gave an R 2 =0.97 for Tg comparison, >20 IU/mL gave an R 2 =0.99, and >115 IU/mL R 2 =0.99.ConclusionsPrior studies have shown that TgAb immunoassays can produce significant qualitative and quantitative differences. In our study, we attempt to validate the use of the Roche immunoassay with a cutoff of 20 IU/mL to minimize interference between Tg and TgAb in order to accurately detect recurrence of thyroid cancer. We found that a TgAb cutoff of 20 IU/mL we maintained acceptable agreement between Tg methods indicating no significant interference up to 20 IU/mL. With the TgAb cutoff of 20 IU/mL, we would be able to reduce sendouts for this cohort from 121 to 42, reducing sendouts by 65% and allowing a faster turnaround time for a significant proportion of our patients.

Serum Thyroglobulin Stability for Immunoassay

Effects of different specimen pretreatment methods on the measurement of thyrotropin stimulating hormone in serum

Pre-Analytical Sample Quality: Metabolite Ratios as an Intrinsic Marker for Prolonged Room Temperature Exposure of Serum Samples

Elucidation of stability profiles of common chemistry analytes in serum stored at six graded temperatures

Stability of serum alanine aminotransferase activity

Mutual interference between serum thyroglobulin and antithyroglobulin antibody in an automated chemiluminescent immunoassay.

Stability of serum biochemical markers during standard long-term storage and with a single thawing

Quantitative and qualitative analysis of stability for 16 serum immunoregulators over 50 freeze–thaw cycles

Mutual interference between serum thyroglobulin and anti-thyroglbulin antibody in chemiluminescent immunoassay

Sex Steroid Hormone Stability in Serum Tubes with and Without Separator Gels

STABILITY OF INTERLEUKIN 6, SOLUBLE INTERLEUKIN 6 RECEPTOR, INTERLEUKIN 10 AND CC16 IN HUMAN SERUM

A Novel Thyroglobulin Immunoassay Using the Specimen-Pretreatment Process Improves the Accuracy of Thyroglobulin Measurements in Anti-Thyroglobulin Positive Specimens

In vitro Stability of Heat Shock Protein 27 in Serum and Plasma Under Different Pre-analytical Conditions: Implications for Large-Scale Clinical Studies

B-085 Optimizing Thyroglobulin Antibody Interference Thresholds to Minimize Turn-around Time

The Stability of Intact Parathyroid Hormone (PTH) in Different Types of Blood Collection Tubes

Influence of Thyroglobulin (Tg) Autoantibodies on Tg levels Measured by Different Methodologies: (IMA, LC-MS/MS and RIA)

An improved procedure for the preparation of the human thyroglobulin and the development of a thyroglobulin autoantibody kit

A Gc-Ms Study of the Stability of Rat Serum Metabolome During the Sample Preparation Procedure

Clinical use of thyroglobulin: not only thyroid cancer

Effect of frozen storage conditions on antithrombin protein C and protein S activity assay stability

Stability of adrenocorticotropic hormone in whole blood samples: effects of storage conditions